News & Insights

Thought Leadership

January 13, 2019

New King & Spalding Report Analyzes Latest Healthcare Industry Trends

Almost nine years after the enactment of the Affordable Care Act, the country is still embroiled in uncertainty over its future as major judicial and congressional activity over the law looms in 2019.

For example, the Democratically controlled House took action on its first day in session to intervene in the Texas lawsuit that recently pronounced the unconstitutionality of the act.

We have endeavored in this edition of Our Insights into Healthcare Industry Trends to give our clients and friends our perspectives on a number of health law topics that are closely tied to political decisions made in Washington and that remain politically charged. These include:

  • The future of the Affordable Care Act, as well as political activity impacting drug pricing and healthcare costs (pp. 1-3);
  • Key government reimbursement trends and the impact of Medicaid changes, administrative priorities to reduce regulatory burdens and court rulings that create opportunities for providers (pp. 22-25);
  • The enforcement priorities of the Department of Justice and HHS Office of Inspector General and how they require adaptation in compliance practices by providers across the country (pp. 4-8);
  • Continued congressional focus on nonprofit tax exemption benefits (pp. 26-27);
  • The antitrust enforcement climate in Washington and increased agency sensitivity to business combinations in the healthcare industry (pp. 20-21); and
  • How government auditors are setting priorities when it comes to nontraditional healthcare providers like durable medical equipment suppliers, pharmacies, and labs (pp. 9-11).

We are also highlighting in this edition how the current health law environment impacts important business decisions our clients make. Topics that explore these issues include:

  • The innovative transaction structures we are involved in on behalf of academic medical center clients (pp. 16-19);
  • Structuring healthcare acquisitions in the Middle East (pp. 12-15);
  • U.S. transactional activity in healthcare (pp. 30-31); and
  • The choices providers face when it comes to participation in tiered networks (pp. 28-29).

Click here to read our full report.